General Information of Disease (ID: DISN1LGK)

Disease Name Escherichia coli meningitis
Definition
A form of gram-negative meningitis that tends to occur in neonates, in association with anatomical abnormalities (which feature communication between the meninges and cutaneous structures) or as opportunistic infections in association with immunologic deficiency syndromes. In premature neonates the clinical presentation may be limited to anorexia; vomiting; lethargy; or respiratory distress. Full-term infants may have as additional features fever; seizures; and bulging of the anterior fontanelle. (From Menkes, Textbook of Child Neurology, 5th ed, pp398-400)
Disease Hierarchy
DISRP9SL: Bacterial meningitis
DISN1LGK: Escherichia coli meningitis
Disease Identifiers
MONDO ID
MONDO_0006753
MESH ID
D020814
UMLS CUI
C0338395
MedGen ID
90920
SNOMED CT ID
192655005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Amikacin DM5PDRB Approved Small molecular drug [1]
Ampicillin DMHWE7P Approved Small molecular drug [2]
Cefotaxime DMEB837 Approved NA [3]
Ceftriaxone DMCEW64 Approved Small molecular drug [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Amikacin FDA Label
2 Ampicillin FDA Label
3 Cefotaxime FDA Label
4 Ceftriaxone FDA Label